Illuminare Biotechnologies

New York, NY · Founded 2016 · Privately Held (backing)

Developer of an intra-operative nerve visualization technology intended to reduce the risk of nerve damage. Illuminare Biotechnologies is based in New York, NY and was founded in 2016. Its last reported valuation was $11.4 million in Aug 2017. It has raised $7.1 million across 1 recorded round; the latest was a $3.6 million seed round in May 2026.

Last reported valuation
$11.4M
Oct 2026
Priced at
—
Total raised
$7.1M
Last round
Seed Round
May 2026

Who backs Illuminare Biotechnologies?

4 investors
InvestorType
Memorial Sloan Kettering Cancer CenterOther
Endo Investors—
GE Aerospace—
Thylacine Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Illuminare Biotechnologies investors

4 investors are on record for Illuminare Biotechnologies, including Memorial Sloan Kettering Cancer Center, Endo Investors, GE Aerospace and Thylacine Capital. The seed round in May 2026 drew 42 investors.

Free account
More of Illuminare Biotechnologies with a free account
  • ·Watch Illuminare Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Illuminare Biotechnologies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View